Lantheus Holdings Set to Showcase Innovations at Conference

Author: Caleb Price Updated: 09-02-2025 08:48 AM

Lantheus Holdings to Shine at the Upcoming Conference

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent name in the radiopharmaceutical sector, recently made waves by announcing that the CEO, Brian Markison, will take the stage at the Morgan Stanley 23rd Annual Global Healthcare Conference. The presentation is scheduled for 7:00 a.m. ET on an upcoming Tuesday, where Lantheus aims to highlight its mission to help healthcare professionals Find, Fight, and Follow diseases effectively.

Strategic Presentation Approach

During this pivotal event, the leadership team from Lantheus will delve into the company's cutting-edge advancements in the field of radiopharmaceuticals. As a leader in this niche, Lantheus emphasizes research and development, striving to improve diagnostic and therapeutic modalities that foster superior patient care and outcomes. This is an excellent opportunity for investors and healthcare stakeholders to gain insight into the strategic direction of Lantheus Holdings.

Webcast Access for Interested Parties

For those eager to engage with the presentation, Lantheus has made it convenient to access via a live webcast through the Investors section of its corporate website. After the live event, a replay will be available online for a minimum of 30 days, allowing interested parties to catch up on invaluable insights at their convenience.

An Overview of Lantheus

Lantheus has carved out an impressive reputation as a go-to source for innovative radiopharmaceutical solutions over the course of nearly 70 years. Headquartered in Massachusetts and operating internationally, the company has expanded to include offices in New Jersey, Canada, Germany, Sweden, and Switzerland. By focusing on life-changing science, Lantheus dedicates itself to helping clinicians enhance patient outcomes through its state-of-the-art technologies.

Company Contact Information

For investor inquiries or communications related to the company's operations, Lantheus encourages interested parties to reach out directly to Mark Kinarney, Vice President of Investor Relations at 978-671-8842, or email ir@lantheus.com. For media inquiries, Melissa Downs, Executive Director of External Communications, can be contacted at 646-975-2533 or via email at media@lantheus.com.

Frequently Asked Questions

What is the purpose of Lantheus's presentation at the conference?

The presentation aims to highlight Lantheus's groundbreaking advancements in radiopharmaceuticals and its commitment to enhancing healthcare outcomes.

How can I access the live webcast?

The live webcast will be available on the Investors section of the Lantheus website, with a replay accessible for at least 30 days afterwards.

What does Lantheus focus on in its operations?

Lantheus specializes in radiopharmaceuticals, developing innovative solutions to aid clinicians in diagnosing and treating diseases effectively.

How long has Lantheus been in operation?

Lantheus has been providing radiopharmaceutical solutions for nearly 70 years, establishing a legacy of excellence in healthcare.

Who can I contact for more information about Lantheus?

Contacts for inquiries include Mark Kinarney for investors and Melissa Downs for media related questions.

About The Author

Hey there I'm Caleb Price, a writer and financial specialist who loves to assist others in understanding the financial world. Having years of practical experience and a solid background in finance, my area of expertise is converting difficult financial ideas into useful, doable insights for my blog and publications. My goal with my writing is to give readers the information and assurance they need to successfully negotiate their financial journeys.

My ability to interact with a wide range of people—from novices starting their investing journey to seasoned investors looking for new approaches—has come from contributing to several financial blogs. Making money approachable and understandable is my goal; this will enable you to make wise choices and realize your financial objectives. We appreciate you coming along on this path to success and financial empowerment on Investors Hangout.

Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.